Publication:
The Role of EGFR, Hepatocyte Growth Factor Receptor (c-Met), c-ErbB2 (HER2-neu) and Clinicopathological Parameters in the Pathogenesis and Prognosis of Chordoma

Loading...
Thumbnail Image
Date
2017-05-01T00:00:00Z
Authors
TOSUNER, ZEYNEP
BOZKURT, SÜHEYLA
KILIÇ, TÜRKER
Yilmaz, Baran
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Sustainable Development Goals
Organizational Units
Journal Issue
Abstract
Objective: Chordoma is a rare malignant bone tumor with a poor outcome. Although radiotherapy and gamma knife surgery have been used for treatment, providing a cure for the tumor is not easy, because of the frequent recurrences. Molecular targeted therapy against tyrosine kinases has been effective in the treatment of malignancies such as breast and lung cancers and brain tumors. We aimed to analyse the histopathological features of chordomas and the immunoexpression profiles of the three receptor tyrosine kinases of EGFR, c-Met and c-Erb-B2 in chordomas. We have correlated these results with recurrence and overall survival status of the patients.
Description
Keywords
Citation
TOSUNER Z., BOZKURT S., KILIÇ T., Yilmaz B., -The Role of EGFR, Hepatocyte Growth Factor Receptor (c-Met), c-ErbB2 (HER2-neu) and Clinicopathological Parameters in the Pathogenesis and Prognosis of Chordoma-, TURKISH JOURNAL OF PATHOLOGY, cilt.33, ss.112-120, 2017